BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 11, 2016
View Archived Issues
Asceneuron discloses glycosidase inhibitors
Read More
PharmaResearch Products and Lipopeptide establish strategic collaboration in wound care
Read More
Scientists report miRNAs that may be associated with mBCC
Read More
PsiOxus Therapeutics begins combination treatment in OCTAVE study
Read More
Gilead Sciences patents compounds to treat HIV
Read More
Han Wha Pharma and Yang Ji Chemical disclose JAK inhibitors
Read More
Prexton Therapeutics introduces mGlu4 receptor PAMs
Read More
Bristol-Myers Squibb describes HIV integrase inhibitors
Read More
University of Dayton reports antineoplastic and antibacterial compounds
Read More
AnaptysBio starts dosing in first-in-human phase I trial of ANB-020
Read More
Senhwa Biosciences enters agreement with CCTG for phase I/II study of CX-5461
Read More
Vericel releases topline results from phase IIb study of ixmyelocel-T
Read More
Phase III data show sarilumab superior to adalimumab in patients with active rheumatoid arthritis
Read More
FDA accepts for review Enbrel sBLA for pediatric chronic severe plaque psoriasis
Read More
Scancell and Karolinska Institutet collaborate to explore role of citrullination in cancer
Read More
Double-blind trial evaluates mexiletine in sporadic amyotrophic lateral sclerosis
Read More
SRI International awarded National Cancer Institute contract to develop cancer treatments
Read More
Bioresorbable sensors may enable wireless data collection in deep tissue and body cavities
Read More
Lundbeck initiates phase III program of Lu-AF-35700 for treatment-resistant schizophrenia
Read More
Enrollment under way in phase III trial of elafibranor for NASH
Read More
Novartis submits sBLA for ofatumumab with fludarabine and cyclophosphamide for relapsed CLL
Read More